Rockefeller Capital Management L.P. - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 128 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q4 2022$86
-99.9%
5,7500.0%0.00%
Q3 2022$73,000
+32.7%
5,7500.0%0.00%
Q2 2022$55,000
-3.5%
5,7500.0%0.00%
Q1 2022$57,000
-14.9%
5,7500.0%0.00%
Q4 2021$67,000
+737.5%
5,750
+666.7%
0.00%
Q3 2021$8,000
-20.0%
7500.0%0.00%
Q2 2021$10,000
-23.1%
7500.0%0.00%
Q1 2021$13,0000.0%7500.0%0.00%
Q4 2020$13,000
+18.2%
7500.0%0.00%
Q3 2020$11,000
-42.1%
7500.0%0.00%
Q2 2020$19,0007500.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q4 2022
NameSharesValueWeighting ↓
Birchview Capital, LP 30,000$560,1000.52%
ADIRONDACK TRUST CO 875$16,2660.01%
CWM, LLC 451$80.00%
BARCLAYS PLC 34,839$6500.00%
OSAIC HOLDINGS, INC. 623$11,6310.00%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders